p53 K316P mutation results in increased liver triglyceride levels and increased rates of d

p53 K316P mutation results in increased liver triglyceride levels and increased rates of d
ST002396 · Metabolomics Workbench

TL;DR — A 9.2 KB metabolomics / lipidomics deposit (ST002396, 1 file(s), liver) in the MASLD / NAFLD / NASH data lake. under-mined portal (Metabolomics Workbench); modality=metabolomics.


0. Summary

Biological premise.

The following premise is sourced from the repository record (not fabricated).

Mouse livers were isolated from four wild type (WT) and four p53 K316P (M) mice for lipidomic analysis. Samples were isolated and flash frozen in liquid nitrogen. Lipids were then extracted from each liver sample and analyzed using mass spectrometry.

Our lab generated the p53 K316P mouse, which mimicks a common amino acid change found in bats. The K316P mutation, found in the nuclear localization signal of p53, results in increased cytoplasmic localization of p53. We found that K316P mutant mice develop several metabolic phenotypes, including increased body fat percentage, and increased liver lipid levels. In order to determine the mechanism through which K316P mutation increases liver lipid levels, we performed metabolomic analysis of mouse livers from WT and K316P mutant mice. Mouse livers were isolated from four wild type (WT) and four p53 K316P (M) mice for lipidomic analysis. Samples were isolated and flash frozen in liquid nitrogen. Lipids were then extracted from each liver sample and analyzed using mass spectrometry.

Every file in this dataset is a metabolomics / lipidomics readout relevant to MASLD / non-alcoholic fatty liver disease (NAFLD) / non-alcoholic steatohepatitis (NASH), landed from Metabolomics Workbench.

Assay and processing.

Modality: metabolomics / lipidomics (repository subtype: metabolomics). Tier-1 (must-have) for this modality = feature × sample intensity matrix (MAF/data table) + sample factors; Tier-2 (recommended) = feature annotation (m/z, RT, HMDB/KEGG ids), author DE/pathway tables, QC pools; Tier-3 (optional / raw) = raw spectra (.mzML/.cdf/vendor), peak-picking parameters. The Completeness line in each dataset block below states, measured from the landed files, which tiers are present.

Sources.

  • ST002396 — Metabolomics Workbench deposit (under-mined portal (Metabolomics Workbench); modality=metabolomics).
  • PMIDs: none recorded in the index for this deposit.
DiseaseMASLD / NAFLD / NASH
Assay / modalitymetabolomics / lipidomics — metabolomics
Organismsunspecified
RepositoryMetabolomics Workbench — NIH Metabolomics Workbench
AccessionST002396
AccessPublic (open); files mirrored in this dataset's input/ folder.
Number of studies1
Number of files1
Total size9,214 bytes (≈ 9.2 KB)

1. Datasets — sample sources, protocols, experiment design and metadata

Landed sources at a glance.

SourceAccessFiles
Metabolomics Workbenchpublic / OPEN-processed1

The deposit at a glance.

AccessionDescriptionOrganismSamplesScale
ST002396under-mined portal (Metabolomics Workbench); modality=metabolomicsunspecifiedn/a1 files · 9.2 KB

ST002396 — p53 K316P mutation results in increased liver triglyceride levels and increased rates of d

Metabolomics Workbench record · 1 files · 9.2 KB

  • Sample source. unspecified material; MASLD/NAFLD/NASH context (under-mined portal (Metabolomics Workbench); modality=metabolomics).

  • Samples and retention. Sample count not declared in the repository index; see the per-sample metadata file(s) listed below.

  • Experiment design. Repository subtype: metabolomics; disease context MASLD/NAFLD/NASH.

  • Metadata available. See the annotated file table below; per-sample metadata ships in the ISA-Tab / SDRF / metadata file(s) where present.

  • Files (annotated).

    FileWhat it is
    ST002396_mwtab.txtMetabolomics Workbench mwTab — study design, sample factors, and named-metabolite × sample data table (112 data rows × 1 cols)
  • How this experiment became a dataset. ST002396 resolved via the Metabolomics Workbench record API → 1 open file(s) fetched into this dataset's input/ folder → sizes verified on disk (9,214 bytes (≈ 9.2 KB)).

  • Completeness (metabolomics / lipidomics). No canonical Tier-1 slot auto-detected among the landed files. Not detected among landed files: feature/intensity table (Tier-1); sample factors (Tier-1); metabolite annotation (Tier-2). (Tiers per the matching modality skill; assessment measured from landed filenames/headers.)


2. Analyses this atlas supports

  • Differential-abundance / pathway analysis. Start from ST002396_mwtab.txt (feature × sample intensities) to run group contrasts and metabolite-set enrichment.
  • Cross-cohort MASLD integration. Combine this deposit (ST002396) with other liver/MASLD datasets in the lake sharing the same modality for meta-analysis.

Reproduce. All files are in this dataset's input/ folder; the source of record is ST002396 (https://www.metabolomicsworkbench.org/rest/study/study_id/ST002396/mwtab/txt). Re-fetch with the MASLD crawler (masld_download_pass.py --only ST002396); sizes are verified on disk and recorded in this dataset's metadata.json.


Citation

p53 K316P mutation results in increased liver triglyceride levels and increased rates of d. Metabolomics Workbench accession ST002396. https://www.metabolomicsworkbench.org/rest/study/study_id/ST002396/mwtab/txt

About this dataset

This 10x Genomics dataset provides single-cell gene expression from liver samples, with disease state recorded as MASLD/NAFLD/NASH.

Analyze it in Drylab

Open this dataset in Drylab and ask a question in plain language. The AI agent loads the files, runs the analysis in a ready sandbox and explains each result. A typical first pass:

  1. Load the filtered feature-barcode matrix (HDF5) and run quality control on counts, genes and mitochondrial reads per cell.
  2. Normalize, select variable genes, then cluster the cells and draw a UMAP.
  3. Annotate clusters with marker genes and compare the cell-type mix between conditions.
  4. Run differential expression between cell types or samples to characterize masld/nafld/nash biology.